GENCORP INC.
2009 EQUITY AND PERFORMANCE INCENTIVE PLAN
Director Stock Appreciation
Rights Agreement
WHEREAS,
(the “Rights Holder”) is a Director of GenCorp Inc.
(the “Company”); and
WHEREAS, the grant
of stock appreciation rights to the Rights Holder has been duly
authorized by a resolution of the Corporate Governance and
Nominating Committee (the “Committee”) of the Board of
Directors and by the Board of Directors (the “Board”)
of the Company effective as of
, 20___(the “Date of Grant”).
NOW, THEREFORE,
pursuant to the Company’s 2009 Equity and Performance
Incentive Plan (the “Plan”), the Company hereby grants
to Rights Holder
(___) Free-Standing Appreciation Rights (“SAR”)
pursuant to this Stock Appreciation Rights Agreement (the
“Agreement”) entitling Rights Holder to obtain, upon
the exercise of SARs on the terms and conditions set forth herein,
a cash payment as determined herein.
1.
Exercisability of SARs .
(a) Unless
and until terminated as hereinafter provided, the SARs subject to
this Agreement will become exercisable, (i) to the extent of
one-half of the total number of SARs granted, on the date which is
six months after the Date of Grant, and (ii) with respect to
the remaining one-half of such SARs, on the date which is one year
after the Date of Grant, on the condition that the Rights Holder
remains a Director of the Company on such dates. To the extent that
the SARs will have so become exercisable, the SARs may be exercised
in whole or in part from time to time.
(b) Notwithstanding
the provisions of Subsection (a) of this Section 1, the
SARs will become immediately exercisable in full upon the
occurrence of a change in control of the Company. For purposes of
this Agreement, the term “change in control” will have
the meaning given such term under the Plan as in effect on the Date
of Grant.
(a) SARs
may be exercised only by delivery of a signed and dated SAR
Exercise Form to the Company in accordance with instructions
provided therewith, which Exercise Form shall state the number of
SARs to be exercised. For all purposes, including the determination
of applicable tax reporting and withholding, the exercise date will
be the date entered next to the Rights Holder’s signature on
the SAR Exercise Form (the “Exercise Date”). The
Company will not fill in the Exercise Date under any
circumstances.
(b) The
Exercise Date can be no earlier than the date the SAR Exercise Form
is delivered to the Company regardless of the method of delivery
(i.e., by fax, by hand, by overnight courier, etc.)
3.
Payment of SAR Value .
(a) Upon
the exercise of SARs in accordance with Section 2, the Company
shall make a cash payment for the SAR Value relating to such
exercise to the Rights Holder.
(b) SAR
Value shall be the product of (i) the number of Shares with
respect to which the SAR is exercised, and (ii) the excess of
the Fair Market Value of a Share on the date of exercise over
$___(the “Grant Price”).
(c) Fair
Market Value shall mean the last sales price reported for the
Shares on the applicable date as reported on the principal national
securities exchange in the United States on which it is then traded
or The NASDAQ Stock Market (if the Shares are so listed), or, if
not so listed, the mean between the closing bid and asked prices of
publicly traded Shares in the over-the-counter market, or, if such
bid and asked prices shall not be available, as reported by any
nationally recognized quotation service selected by the Company, or
as determined by the Committee in a manner consistent with the
provisions of the Code. If, however, the required accounting
standards used to account for the SARs granted to the Rights Holder
are substantially modified subsequent to the Effective Date of the
Plan such that fair value accounting for such SARs becomes
required, the Committee shall have the ability to determine the
SAR’s Fair Market Value based on the relevant facts and
circumstances.
(a)
Exercisable SARs. SARs that have become exercisable will
terminate on the date which is seven years from the Date of
Grant.
(b)
SARs Not Yet Exercisable . SARs that have not become
exercisable prior to the termination of the Rights Holder’s
service as a Director with the Company for any reason will
terminate on the date of termination of such service.
|